￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Timing and considerations for discontinuing aceminib in the treatment of chronic myelogenous leukemia

2026-02-01 22:25:32

Check Details
Novel BCR-ABL1 inhibitor aximini

2026-02-01 22:25:32

Check Details
Discussion on the long-term medication selection of aceminib in the treatment of patients with chronic myelogenous leukemia

2026-02-01 22:25:32

Check Details
Several major side effects and coping strategies to be aware of in the treatment of CML with Aceminib

2026-02-01 22:25:32

Check Details
Aceminib discontinuation guide

2026-02-01 22:25:32

Check Details
Analysis and response strategies for drug resistance in CML treated with aceminib

2026-02-01 22:25:32

Check Details
How effective is Aceminib in the treatment of chronic myeloid leukemia?

2026-02-01 22:25:32

Check Details
Domestic selling price and medical insurance reimbursement status of Vancevi in u200bu200b2024

2026-02-01 22:25:32

Check Details
Price information and formal purchasing channels of imitation version of WANSAVI

2026-02-01 22:25:32

Check Details
Correct dosage guide and key safety reminders

2026-02-01 22:25:32

Check Details
Overview of generic drug costs and purchasing considerations for Vancevi

2026-02-01 22:25:32

Check Details
Genuine Lorlatinib (Lorlatinib) Buying Guide and Price Overview

2026-02-01 22:25:32

Check Details
Category
相关知识